3627 results for «555»
3627 results
Intervening in aortic regurgitation: are we finally there?
30 Sep 2025 – From PCR Gulf Valves 2025
Explore the evolving landscape of transcatheter treatment for aortic regurgitation in this informative session. Understand the anatomical and clinical criteria essential for selecting candidates for transcatheter therapy, review the latest device options supported by real-world and investigational data, and learn to navigate procedural challenges with advanced...
Improving aortic stenosis diagnostic accuracy
30 Sep 2025 – From PCR Gulf Valves 2025
Enhance your diagnostic accuracy in aortic stenosis through this targeted session. Learn to differentiate among various types of aortic stenosis, avoid common echocardiographic diagnostic errors, and master transesophageal echocardiography (TEE) measurement techniques to effectively guide transcatheter aortic valve implantation (TAVI), especially in emergency settings.
Most impactful trials in structural heart disease 2024/2025
30 Sep 2025 – From PCR Gulf Valves 2025
Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...
A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)
30 Oct 2024
Nicola Ryan provides her take on the ECLIPSE trial presented by Ajay J. Kirtane at TCT 2024 in Washington.
Author
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry
17 Sep 2022
Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.
Author
